Navigation Links
EAU Technologies Receives Patent for Empowered Water(TM)
Date:1/22/2009

arget="_new">www.eau-x.com

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements may include without limitation, our expectations about the growth and the potential for the company, and Mr. Bradley's abilities to lead the company in that growth. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk associated with successfully developing our business in evolving markets, our need for additional capital, our continuing operating losses, the ability of our management to conduct distribution activities and sell products, possible failure to successfully develop new products, vulnerability to competitors due to lack of patents on our products, and other risk factors listed in our annual report on Form 10-KSB for the year ended December 31, 2007 and our other SEC reports. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking state
'/>"/>

SOURCE EAU Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
2. BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies
3. Neurobiological Technologies Announces Suspension of Viprinex Development
4. JMAR Technologies Raises Awareness of BioSentry -- A High Tech Counter to Bioterrorism
5. ImmunoVaccine Technologies Presents at OneMed Place Finance Forum
6. Volcano Announces Closing of Axsun Technologies Acquisition
7. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
8. ISTO Technologies to Present at OneMedPlace Emerging Company Finance Conference
9. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
10. BioStorage Technologies Partners with Susan G. Komen for the Cure(R) Tissue Bank at the IU Simon Cancer Center in Breast Cancer Research Initiative
11. RainDance Technologies and Harvard University to Share in First Massachusetts Life Sciences Center Cooperative Research Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 The Center for ... Communications, is pleased to announce the full ... Accounting and Reporting Congress . The forum ... on March 16-17, 2010. ,, Over 1,500 ... have attended this premier event since its ...
(Date:12/15/2009)... Belgium, December 15 , ... Designed to Evaluate the Ability of,Cardiopoietic Cells to ... Cardio3 BioSciences, a leading Belgian biotechnology company specialising,in ... today that it has completed, two months ahead ... pivotal Phase II/III trial of C-Cure, a,unique stem ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... The third edition of Infusion Nursing: ... by the Infusion Nurses Society (INS), includes Totect(®), ... Anthracyclines are a group of chemotherapy medications including ... used in the treatment of various types of ... According to the INS publication: "In September 2007, ...
Breaking Biology Technology:CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... between spine companies, according to ... According to Millennium,Research Group,s (MRG,s) Global Competitor ... fusion market is rife with competitive,movements -- including ... over $5.2 billion by 2012., In 2007 ...
... 26th at 2:30pm ET, NEW YORK, June 24 ... that Michael S. Weiss, the Company,s,Chairman and Chief Executive ... Healthcare Conference being held in New York City., ... June 26th at,2:30pm ET and will be accessible from ...
... Instrumentation Laboratory,(IL) today announced that it has shipped ... recipient for this instrument was Scripps,Health, based in ... GEM Premier 4000,analyzers to customers around the world ... breakthrough analyzer underlines its tremendous,customer appeal., Scripps ...
Other Biology Technology:Competition Alive in the Global Spine Market 2Keryx Biopharmaceuticals to Present at the Jefferies & Co. Healthcare Conference 2Instrumentation Laboratory Ships 1000th GEM Premier 4000 Analyzer to Scripps Health 2Instrumentation Laboratory Ships 1000th GEM Premier 4000 Analyzer to Scripps Health 3
(Date:12/15/2009)... . , Leipzig: Species distribution models are of only ... This is the finding of a study of the ... analysed data on species distribution, climate, land cover and ... species. Judging by the large differences in climate niches ... fast to changing climatic conditions. This in turn makes ...
(Date:12/15/2009)... organism, but there are currently few resources that ... tissues in this species. A newly released ... Cold Spring Harbor Laboratory Press fills this gap. ... for the preparation, enumeration, and microscopic examination of ... in the mouse. The laboratory manual is ...
(Date:12/14/2009)... 14, 2009) -- Researchers at Rice University and Baylor ... that can be tracked in real time with MRI ... with a fluorescent dye and kills them with heat. ... from a growing field called "theranostics" that develops technologies ... a single procedure. , The research is available online ...
Breaking Biology News(10 mins):Species distribution models are of only limited value for predicting future mammal distributions 2New source of classical techniques for blood-based studies in the laboratory mouse 2Tracking new cancer-killing particles with MRI 2Pharmacyclics Inc Announces Presentation of Interim Results From Phase I Trial of Its First In Human Btk Inhibitor PCI 32765 62796 1Pharmacyclics Inc Announces Presentation of Interim Results From Phase I Trial of Its First In Human Btk Inhibitor PCI 32765 62796 2Pharmacyclics Inc Announces Presentation of Interim Results From Phase I Trial of Its First In Human Btk Inhibitor PCI 32765 62796 3Pharmacyclics Inc Announces Presentation of Interim Results From Phase I Trial of Its First In Human Btk Inhibitor PCI 32765 62796 4Pharmacyclics Inc Announces Presentation of Interim Results From Phase I Trial of Its First In Human Btk Inhibitor PCI 32765 62796 5Roche Diagnostics Opens State of the Art Training Center in California 6802 1Roche Diagnostics Opens State of the Art Training Center in California 6802 2Pitt study suggests craving hinders comprehension without your realizing it 62794 1Pitt study suggests craving hinders comprehension without your realizing it 62794 2
... portion of plant seeds is endosperm. It has the ... early stages of its development. In flowering plants, there ... and endosperm. , They develop together into mature ... two parts of the seeds, has been unclear to ...
... researchers led by Nongjian Tao and Peiming Zhang has developed ... , Their results, published in the journal Proceedings of the ... possibility of directly identifying these mutations, or single nucleotide polymorphisms ... single DNA molecule. , SNPs are buried in the ...
... Indonesia are carrying several retroviruses that are capable of ... University of Washington researchers. The results indicate that contact ... countries, could represent a little-known path for viruses to ... eventually cause human disease. Performing monkeys are animals that ...
Other Biology News:The secret love life of plants 2ASU researchers 'wire' DNA to identify mutations 2ASU researchers 'wire' DNA to identify mutations 3Performing monkeys in Asia carry viruses that could jump species to humans 2Performing monkeys in Asia carry viruses that could jump species to humans 3
... Free Epitope Design consultation. Peptide ... 17 amino acids). Conjugation to KLH. ... Immunization of 2 New Zealand white ... 5 immunizations and 4 production bleeds. ...
... Solution is a comprehensive suite of ... specifically designed to reliably extract biological ... genomic studies containing thousands of samples, ... efficient and will analyze large data ...
Kit contains: Bio-Rad Amplification Reagent, 2x Amplification Diluent, Streptavidin-HRP, Blocking Reagent, and Phosphate Buffered Saline....
These macrocarriers are for the biolistic PDS-1000 He and Hepta systems. Supplied as 500 macrocarriers....
Biology Products: